SOD1 and myocardial infarction: In the present study, we provide a novel working mechanism in which E2/ER upregulates mitochondrial p38β activity, with subsequent phosphorylation of the dismutase at S106 and T79 by p38β, leading to enhanced SOD activity, suppressed ROS and reduced myocardial infarct post I/R.